Stanford, CANCT06073132Now EnrollingIRB Ready

Epidermolysis Bullosa Simplex Clinical Trial in Stanford, CA

Access cutting-edge epidermolysis bullosa simplex treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.

Sponsored by TWi Biotechnology, Inc.

Quick Self-Assessment

See if you qualify for this Stanford location

Preparing your pre-screening questions...

Expert Care in Stanford

Access epidermolysis bullosa simplex specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related epidermolysis bullosa simplex treatment provided free

Apply for This Stanford Location

Check if you qualify for this epidermolysis bullosa simplex clinical trial in Stanford, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Stanford

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Stanford site if eligible
  4. 4Begin participation

About This Epidermolysis Bullosa Simplex Study in Stanford

The proposed Phase 2/3 trial with double-blind and open-label extension phases is an international, multicenter study designed to assess the efficacy and safety of diacerein 1% ointment in patients with generalized EBS.

Sponsor: TWi Biotechnology, Inc.

Who Can Participate

Inclusion Criteria

Patient is at least 6 months old at Visit 2 (Day 1/Baseline A). 2. Patients has been clinically diagnosed with severe EBS or intermediate EBS, confirmed by documented genetic diagnosis to have autosomal dominant mutations in KRT5 or KRT14 gene. 3. Patient with ≥ 3% BSA of EBS lesions excluding palms and soles at Visit 2 (Day 1/Baseline A). 4. Patient's EBS lesions within the Treatment Area have an IGA score of ≥3 at Visit 2 (Day 1/Baseline A). 5. Patient/caregiver agrees to follow study medication application instructions. 6. Patient (and caregiver/legal guardian) agrees to report use of all prescription and over-the-counter medications, including topical therapies applied to the body, e.g., medical cleansers, bleach cleansers, bleach baths, topical antiseptics, topical disinfectants, etc. for the duration of the study. 7. Patient (and caregiver/legal guardian) is willing and able to comply with all study visits and all the protocol requirements, including compl

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Stanford?

Yes, this clinical trial (NCT06073132) has an active research site in Stanford, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Epidermolysis Bullosa Simplex Treatment Options in Stanford, CA

If you're searching for epidermolysis bullosa simplex treatment options in Stanford, CA, this clinical trial (NCT06073132) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epidermolysis bullosa simplex specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all epidermolysis bullosa simplex clinical trials near you to find additional studies recruiting in your area.

More Sleep Apnea Trials in Stanford, CA

See all sleep apnea clinical trials recruiting in Stanford — not just this study.

Browse Sleep Apnea Trials in Stanford →

Browse More Trials by Condition

Sleep Apnea TrialsAll Conditions →

Ready to Join in Stanford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Stanford, CA